ethinyl estradiol-norgestrel combination and Dyslipidemias

ethinyl estradiol-norgestrel combination has been researched along with Dyslipidemias in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kim, IK; Olatunji, LA; Seok, YM; Usman, TO	1

Other Studies

1 other study(ies) available for ethinyl estradiol-norgestrel combination and Dyslipidemias

Article	Year
Activation of cardiac renin-angiotensin system and plasminogen activator inhibitor-1 gene expressions in oral contraceptive-induced cardiometabolic disorder. Archives of physiology and biochemistry, 2017, Volume: 123, Issue:1 Topics: Aldosterone; Animals; Ataxia Telangiectasia Mutated Proteins; Cardiovascular Diseases; Contraceptives, Oral, Combined; Corticosterone; Dyslipidemias; Ethinyl Estradiol-Norgestrel Combination; Female; Glucose Intolerance; Heart; Hyperinsulinism; Hypertension; Insulin Resistance; Metabolic Syndrome; Myocardium; Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Random Allocation; Rats, Sprague-Dawley; Renin-Angiotensin System; Up-Regulation	2017

Article

Year

Activation of cardiac renin-angiotensin system and plasminogen activator inhibitor-1 gene expressions in oral contraceptive-induced cardiometabolic disorder.

Archives of physiology and biochemistry, 2017, Volume: 123, Issue:1

Topics: Aldosterone; Animals; Ataxia Telangiectasia Mutated Proteins; Cardiovascular Diseases; Contraceptives, Oral, Combined; Corticosterone; Dyslipidemias; Ethinyl Estradiol-Norgestrel Combination; Female; Glucose Intolerance; Heart; Hyperinsulinism; Hypertension; Insulin Resistance; Metabolic Syndrome; Myocardium; Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Random Allocation; Rats, Sprague-Dawley; Renin-Angiotensin System; Up-Regulation

2017